Effectiveness of the quadrivalent high-dose influenza vaccine for prevention of cardiovascular and respiratory events in people aged 65 years and above: rationale and design of a real-world pragmatic randomized clinical trial
Publication date: Available online 13 March 2021Source: American Heart JournalAuthor(s): Rosalind Hollingsworth, Arto Palmu, Stephanie Pepin, Martin Dupuy, Anju Shrestha, Jukka Jokinen, Ritva Syrjänen, Joshua Nealon, Sandrine Samson, Iris De Bruijn
Source: American Heart Journal - Category: Cardiology Source Type: research
More News: Cardiology | Cardiovascular | Clinical Trials | Heart | Influenza | Influenza Vaccine | Respiratory Medicine | Vaccines